Teva Pharmaceutical Industries (TEVA) Long-Term Debt Issuances (2009 - 2025)

Teva Pharmaceutical Industries (TEVA) has reported Long-Term Debt Issuances for 6 consecutive years, with $2.3 billion the latest figure, recorded in Q2 2025.

• Quarterly Long-Term Debt Issuances changed N/A year-over-year to $2.3 billion in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 168.49% YoY) and the FY2025 annual result came in at $2.3 billion, changed N/A from the prior year.
• Long-Term Debt Issuances advanced to $2.3 billion in Q2 2025 per TEVA's latest filing, from $1.4 billion in the prior quarter.
• Over the last five years, Long-Term Debt Issuances for TEVA reached as high as $2.5 billion in Q1 2023 and fell as low as $1.4 billion in Q1 2025.